Angioplasty Summit 2004 > Syllabus

Welcome
Course Director
Hot Topic
Invited Faculty
Meeting at a
Glance
Program
Abstracts
Poster Abstracts -
Guideline -
Syllabus
Factoid
Expert Lectures
Gallery 2004
Hotel
Accommodations
Exhibition
Sights of Korea
Waiting times, revascularization modality, and outcomes after acute myocardial infarction at hospitals with and without on-site revascularization facilities in Canada.
A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.
Danish multicenter randomized study on fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANish trial in Acute Myocardial Infarction-2 (DANAMI-2).
ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction.
Collaborative Angiographic Patency Trial Of Recombinant Staphylokinase (CAPTORS II).
Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.
Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study.
Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial.
Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality.
Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis.
Outcome of urgent and elective percutaneous coronary interventions after pharmacologic reperfusion with tenecteplase combined with unfractionated heparin, enoxaparin, or abciximab.
A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
Influence of thrombolytic therapy, with or without intra-aortic balloon counterpulsation, on 12-month survival in the SHOCK trial.
Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials.
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction.
Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials.
Prognostic value of ST-segment resolution-when and what to measure.
Relation of mortality of primary angioplasty during acute myocardial infarction to door-to-Thrombolysis In Myocardial Infarction (TIMI) time.
Prehospital thrombolysis with reteplase: the Nijmegen/Rotterdam study.
Does 24-hour ST-segment resolution postfibrinolysis add prognostic value to a Q wave? An ASSENT 2 electrocardiographic substudy.
Outcomes of primary coronary angioplasty and angioplasty after initial thrombolysis in the treatment of 374 consecutive patients with acute myocardial infarction.
Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis.
Current status and future prospects for acute myocardial infarction therapy.
Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study.
Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction.
Prehospital management of acute ST-elevation myocardial infarction: a time for reappraisal in North America.
Randomized comparison of percutaneous transluminal coronary angioplasty and medical therapy in stable survivors of acute myocardial infarction with single vessel disease: a study of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte.
Primary percutaneous transluminal coronary angioplasty accelerates early myocardial reperfusion compared to thrombolytic therapy in patients with acute myocardial infarction.
Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarction. Cohen, M. G., E. Tuero, et al.